luteinized unruptured follicle syndrome
Conditions
Interventions
Experimental group:G-CSF( 0.9 ml : 150 ug) is injected 24-48 hours prior to HCG administration
Control group:Inject placebo 0.9 ml (normal saline) 24-48 hours before using HCG
Sponsors
The Second Nanning People’s Hospital
Eligibility
Sex/Gender
Female
Age
22 Years to 39 Years
Inclusion criteria
Inclusion criteria: 1. The age of the patient is 22-39 years old, the menstrual cycle is normal, and the level of basic reproductive endocrine is normal; 2. Have not used non-steroidal drugs and contraceptives in the past six months, and have not received radiotherapy and chemotherapy; 3. The woman has a sound female reproductive tract structure and both fallopian tubes are unobstructed or at least one fallopian tube is unobstructed; 4. Both husband and wife voluntarily accept artificial insemination for assisted pregnancy, and sign an informed consent before the operation.
Exclusion criteria
Exclusion criteria: 1. Caused by factors such as hyperprolactinemia, abnormal thyroid function, pelvic local anatomy (such as moderate to severe endometriosis, pelvic inflammatory disease, pelvic surgery leading to ovarian surface adhesion, ovarian capsule thickening) and other factors Patients with LUFS; 2. White blood cell (WBC) count >= 10000 /ul at the time of administration; 3. Patients with serious diseases of liver, kidney and heart, and allergies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of LUFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate; | — |
Countries
China
Contacts
Public ContactLi Ning
The Second Nanning People’s Hospital
Outcome results
None listed